Mehalick David (CIK 1846623) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy COEP (148,875 shares), Buy COEP (51,250 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | Coeptis Therapeutics Holdings, Inc. (COEP) | CEO and President | Buy | 148,875 | $1.0M |
| 2026-02-13 | Coeptis Therapeutics Holdings, Inc. (COEP) | CEO and President | Buy | 51,250 | $0 |
Source: SEC Form 4 filings · as of 2026-02-13